Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

November 2024

Pilatus Biosciences to Unveil Breakthrough Preclinical Data at SITC 2024: PLT012’s Transformative Potential in Liver Metastasis Treatment

November 2024

Pilatus Biosciences Inc. Receives Orphan Drug Designation from FDA for PLT012 in Treatment of Liver and Intrahepatic Bile Duct Cancer

October 2024

Pilatus Biosciences Announces Preclinical Data of Anti-PD-L1/IL-10 Immunocytokine PLT011 at SITC 2023

March 2024

Pilatus Biosciences Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling Preclinical Proof of Concept Data on PLT012, Highlighting its Role in Reprogramming the Tumor Microenvironment against Cancer

Upcoming Events

November 5, 2025

-

November 9, 2025

National Harbor, Maryland

SITC Maryland 2025

More Info